Elevated S100P expression has been found in several other cancers, including colorectal [38], lung [62,63], where it correlates with the activity of the oncogenic PI3K/AKT signaling pathway, and gall bladder cancers [64]. The gene discussed is S100P; the disease is gallbladder cancer.